Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2025-12-24 @ 11:20 PM
NCT ID:
NCT00453856
Eligibility Criteria:
Inclusion Criteria:
* Male and female outpatients
* Aged 6 to 59 months
* Body weight between 7.5 to 30 kg
* uncomplicated falciparum malaria with parasitaemia between 1,000/µL and 200,000/µL
* Ability to tolerate oral therapy
* Informed consent, oral agreement of the child if appropriate
Exclusion Criteria:
* Still in IPTi trial and/or still in any other intervention trial
* Known G6PD-deficiency
* Presence of severe malnutrition
* Inability to drink or breastfeed
* Recent history of convulsions, lethargy or unconsciousness;
* Signs of severe and complicated
* Mixed/mono infection that includes a non-P. falciparum species.
* Hb \< 7g/dl
* Inability to attend stipulated follow-up visits.
* History of hypersensitivity reactions to the drug being evaluated
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Months
Maximum Age:
59 Months
Study:
NCT00453856
Study Brief:
Protocol Section:
NCT00453856